Solar Foods Oyj

Solar Foods is a Finnish food technology company built around the Solein protein ingredient, which is produced through a proprietary fermentation-based process rather than conventional agriculture. The business develops, manufactures, and commercializes protein raw materials and related applications for food and nutrition customers, with an international market focus.

57

2.56

1.52

— Solar Foods Oyj
%
Solein ingredient70% Protein raw material sold for use in food and nutrition products.
Health & Performance Nutrition applications15% Application-specific concepts and formulations built around Solein.
Technology development and commercialization15% Development work tied to production process, organism platform, and scale-up.

Solar Foods sells into food and nutrition companies that need a high-protein ingredient with stable supply and a...

  • Health & Performance Nutrition brandsprimary

    Buy Solein for protein-rich nutrition products where functionality and supply stability matter.

  • Food manufacturerssecondary

    Use Solein as an ingredient in broader food applications that need protein enrichment.

  • Consumer brands and formulatorssecondary

    Test and launch products using Solein-based concepts to validate market demand.

  • Alternative protein buyersemerging

    Seek non-animal protein inputs as an alternative to whey and other conventional sources.

Solar Foods is headquartered in Finland, but its commercial ambition is international and the reports explicitly...

  • Finland is the company base and core development location
  • United States is the first named target market for commercialization
  • Commercial model is built for international food and nutrition customers
  • Factory 02 is the planned scale-up manufacturing location
  • Global market access matters for ingredient adoption and customer reach

Solar Foods is focused on turning Solein from a technology platform into a commercial ingredient business, with Health...

01
Commercialize Solein in Health & Performance Nutritionshort-term

This is the first target market and the main route to early revenue generation.

02
Expand production capacity through Factory 02medium-term

Scale-up is needed to support larger customer volumes and broader commercialization.

03
Strengthen product and application developmentmedium-term

Customer adoption depends on proving functionality in real formulations.

Solar Foods remains exposed to early-stage commercialization risk, including the possibility that demand ramps more...

critical

Funding dependence

The company needs additional capital, loans, and grants to finance commercialization and capacity build-out.

Scope
Corporate financing and dilution risk
Materiality
high
high

Slow commercialization before Factory 02

Meaningful revenue is expected to depend on future production capacity and customer adoption.

Scope
Revenue timing and scale-up risk
Materiality
high
high

Technology and scale-up execution

A novel fermentation-based protein process must work reliably at industrial scale.

Scope
Production yield, quality, and cost risk
Materiality
high
medium

Competitive alternative proteins

Customers can choose from whey, plant-based, and other emerging protein sources.

Scope
Pricing and market share pressure
Materiality
medium
medium

Macroeconomic and geopolitical uncertainty

Global trade disruption, tariffs, and conflict can affect customer demand and planning.

Scope
International market exposure
Materiality
medium
Capitalized development costs
Affects intangible assets, operating expense, and future write-down risk
Government grants
Reduces net investment and influences reported R&D intensity
Lease commitments
Affects lease liabilities, depreciation, and interest expense
Contingent VAT on property investment
Could create a future liability if taxable use declines
Share-based compensation and option dilution
Affects equity, EPS dilution, and compensation expense

: 11/08/2026